10-Q – Page 180 – China Stock Advice

EVK [Ever-Glory International,] 10-Q: FORM 10-Q x For the quarterly period ended

[FORM 10-Q x For the quarterly period ended June 30, 2011 o For the transition period from ____________ to ____________ Ever-Glory International Group Inc. Florida 65-0420146 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Ever-Glory Commercial Center, 509 Chengxin Road, Jiangning Development Zone, Nanjing, Jiangsu Province, People’s Republic of China (8625) 5209-6875 x o Yes x] [I, Edward Yihua Kang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ending June 30, 2011 of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [I, Jiansong Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ending June 30, 2011 of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Section 906 of Sarbanes-Oxley Act of 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. (Principal ExecutiveOfficer)] [Section 906 of Sarbanes-Oxley Act of 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. (Principal Finance Officer)]

By info| 2016-03-02T16:30:23+00:00 August 10th, 2011|Categories: Chinese Stocks, EVK, Webplus ver|Tags: 0000943184, 10-Q, 2011-08-10, 2300, APPAREL and OTHER FINISHED PRODS OF FABRICS and SIMILAR MATERIAL, EVK|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x June 30, 2011 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including area code)] [AMENDED AND RESTATED BYLAWS OF CHINA PHARMA HOLDINGS, INC. (Effective August 9, 2011) SECTION 1. OFFICES 1.1. Registered Office. The registered office of the corporation shall be established and maintained at 1209 Orange Street, Corporation Trust Center, Wilmington, New Castle County, Delaware 19801. 1.2. Principal Office. The principal office of the Corporation shall be located at the principal place of] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 10, 2011 -------------------------------- President and Chief Executive Officer EX-32.1 5 cphi10qex321063011.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 10, 2011 --------------------- (principal financial officer and principal accounting officer) EX-32.2 6 cphi10qex322063011.htm]

By info| 2016-03-03T19:18:51+00:00 August 10th, 2011|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q, 2011-08-10, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: FORM 10-Q (Mark One) x June 30, 2011

[FORM 10-Q (Mark One) x June 30, 2011 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including area code)] [AMENDED AND RESTATED BYLAWS OF CHINA PHARMA HOLDINGS, INC. (Effective August 9, 2011) SECTION 1. OFFICES 1.1. Registered Office. The registered office of the corporation shall be established and maintained at 1209 Orange Street, Corporation Trust Center, Wilmington, New Castle County, Delaware 19801. 1.2. Principal Office. The principal office of the Corporation shall be located at the principal place of] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 10, 2011 -------------------------------- President and Chief Executive Officer EX-32.1 5 cphi10qex321063011.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 10, 2011 --------------------- (principal financial officer and principal accounting officer) EX-32.2 6 cphi10qex322063011.htm]

By info| 2016-03-03T19:19:51+00:00 August 10th, 2011|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-Q, 2011-08-10, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

EVK [Ever-Glory International,] 10-Q: (Original Filing)

[FORM 10-Q x For the quarterly period ended June 30, 2011 o For the transition period from ____________ to ____________ Ever-Glory International Group Inc. Florida 65-0420146 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Ever-Glory Commercial Center, 509 Chengxin Road, Jiangning Development Zone, Nanjing, Jiangsu Province, People’s Republic of China (8625) 5209-6875 x o Yes x] [I, Edward Yihua Kang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ending June 30, 2011 of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [I, Jiansong Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ending June 30, 2011 of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Section 906 of Sarbanes-Oxley Act of 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. (Principal ExecutiveOfficer)] [Section 906 of Sarbanes-Oxley Act of 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. (Principal Finance Officer)]

By info| 2016-03-02T16:29:32+00:00 August 10th, 2011|Categories: Chinese Stocks, EVK, SEC Original|Tags: 0000943184, 10-Q, 2011-08-10, 2300, APPAREL and OTHER FINISHED PRODS OF FABRICS and SIMILAR MATERIAL, EVK|0 Comments

EVK [Ever-Glory International,] 10-Q: (Original Filing)

[FORM 10-Q x For the quarterly period ended June 30, 2011 o For the transition period from ____________ to ____________ Ever-Glory International Florida 65-0420146 (State or other jurisdiction oforporation or organization) (I.R.S. Employer Identification No.) Ever-Glorymmercial Center, 509 Chengxin Road, Jiangning Development Zone, Nanjing, Jiangsu Province, Peoples Republic of China] [I, Edward Yihua Kang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ending June 30, 2011 of Ever-Glory International,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [I, Jiansong Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ending June 30, 2011 of Ever-Glory International,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [Section 906 ofrbanes-Oxley Act of 2002 1. 2. The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. (PrincipalExecutiveOfficer) f10q0611ex32i_everglory.htm 4 EX-32.1] [Section 906 ofrbanes-Oxley Act of 2002 1. 2. The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. (Principal Finance Officer) f10q0611ex32ii_everglory.htm 5 EX-32.2]

By info| 2016-02-07T05:43:54+00:00 August 10th, 2011|Categories: Chinese Stocks, EVK, SEC Original|Tags: 0000943184, 10-Q, 2011-08-10, 2300, APPAREL and OTHER FINISHED PRODS OF FABRICS and SIMILAR MATERIAL, EVK|0 Comments

EVK [Ever-Glory International,] 10-Q: FORM 10-Q x For the quarterly period ended

[FORM 10-Q x For the quarterly period ended June 30, 2011 o For the transition period from ____________ to ____________ Ever-Glory International Florida 65-0420146 (State or other jurisdiction oforporation or organization) (I.R.S. Employer Identification No.) Ever-Glorymmercial Center, 509 Chengxin Road, Jiangning Development Zone, Nanjing, Jiangsu Province, Peoples Republic of China] [I, Edward Yihua Kang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ending June 30, 2011 of Ever-Glory International,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [I, Jiansong Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ending June 30, 2011 of Ever-Glory International,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [Section 906 ofrbanes-Oxley Act of 2002 1. 2. The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. (PrincipalExecutiveOfficer) f10q0611ex32i_everglory.htm 4 EX-32.1] [Section 906 ofrbanes-Oxley Act of 2002 1. 2. The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. (Principal Finance Officer) f10q0611ex32ii_everglory.htm 5 EX-32.2]

By info| 2016-02-07T05:44:29+00:00 August 10th, 2011|Categories: Chinese Stocks, EVK, Webplus ver|Tags: 0000943184, 10-Q, 2011-08-10, 2300, APPAREL and OTHER FINISHED PRODS OF FABRICS and SIMILAR MATERIAL, EVK|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x June 30, 2011 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Delaware 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China)] [AMENDED AND RESTATED BYLAWS OF CHINA PHARMAS, (Effective August 9, 2011) SECTION 1. OFFICES 1.1. Registered Office. The registered office of therporation shall be established and maintained at 1209 Orange Street,rporation Trust Center, Wilmington, Newstleunty, Delaware 19801. 1.2. Principal Office. The principal office of therporation shall be located at the principal place of business of] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:August 10, 2011 -------------------------------- President and Chief Executive Officer cphi10qex321063011.htm 5 EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:August 10, 2011 --------------------- (principal financial officer and principal accounting officer) cphi10qex322063011.htm 6 EX-32.2]

By info| 2016-02-07T22:52:19+00:00 August 10th, 2011|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q, 2011-08-10, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: FORM 10-Q (Mark One) x June 30, 2011

[FORM 10-Q (Mark One) x June 30, 2011 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Delaware 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China)] [AMENDED AND RESTATED BYLAWS OF CHINA PHARMAS, (Effective August 9, 2011) SECTION 1. OFFICES 1.1. Registered Office. The registered office of therporation shall be established and maintained at 1209 Orange Street,rporation Trust Center, Wilmington, Newstleunty, Delaware 19801. 1.2. Principal Office. The principal office of therporation shall be located at the principal place of business of] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:August 10, 2011 -------------------------------- President and Chief Executive Officer cphi10qex321063011.htm 5 EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:August 10, 2011 --------------------- (principal financial officer and principal accounting officer) cphi10qex322063011.htm 6 EX-32.2]

By info| 2016-02-07T22:53:11+00:00 August 10th, 2011|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-Q, 2011-08-10, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CBPO [China Biologic Products] 10-Q: FORM 10-Q (Mark One) [X] For the quarterly

[FORM 10-Q (Mark One) [X] For the quarterly period ended: June 30, 2011 [ ] For the transition period from ____________to _____________ CHINA BIOLOGIC PRODUCTS, INC. Delaware 75-2308816 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) No. 14 East Hushan Road Taian City, Shandong 271000 (+86) 538-620-2306 ____________________________________________________________________________ (Former name, former address and former fiscal year,] [CERTIFICATIONS I, Chao Ming Zhao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Y. Tristan Kuo, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th (Principal Financial Officer)]

By info| 2016-04-03T03:09:32+00:00 August 9th, 2011|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: 0001369868, 10-Q, 2011-08-09, 2836, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

ONP [Orient Paper] 10-Q: (Original Filing)

[] [I, Zhenyong Liu certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Orient Paper, Inc.; ss 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [I, Winston C. Yen, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Orient Paper, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION 18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Zhenyong Liu Chief Executive Officer EX-32.1 12 v230852_ex32-1.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Winston C. Yen Chief Financial Officer (principal financial andaccounting officer) EX-32.2 13 v230852_ex32-2.htm]

By info| 2016-03-20T00:19:15+00:00 August 9th, 2011|Categories: Chinese Stocks, ONP, SEC Original|Tags: 0001358190, 10-Q, 2011-08-09, 2670, CONVERTED PAPER and PAPERBOARD PRODS (NO CONTAINERS/BOXES), ONP|0 Comments